US Earnings Financial Results SEC Filings — August 13, 2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

Classover Holdings, Inc. reported a net loss of $2.5M for Q2 2026 and $6.7M for H1 2026, widening from $3.9M and $4.2M in the prior-year periods. Total revenues declined 33.6% YoY in Q2 to $481,831 and 35.1% YoY in H1 to $1.0M, driven by a drop in service revenues. However, operating losses narrowed significantly, and the company raised $3.0M in a private placement and ended the period with $8.9M in cash, up from $2.8M at year-end 2025.

• · Selling and marketing expenses decreased 50.5% YoY in Q2 2026 to $54,526, and 57.0% in H1 2026 to $99,547.
• · General and administrative expenses decreased 32.9% YoY in Q2 2026 to $1,267,947, but only 4.0% in H1 2026 to $2,364,103.
• · Research and development expenses increased 67.0% YoY in Q2 2026 to $37,555, and 80.9% in H1 2026 to $52,091.
• · The company sold $4.0M in crypto assets during H1 2026, reducing its crypto investment accounts from $7.3M to just $21,773.
• · A $3.0M capital contribution from a private placement and $9.5M in convertible debt conversions to equity strengthened the balance sheet.
• · The company repurchased $3,518 in treasury stock during Q2 2026.
• · Intangible assets were acquired for $1.25M cash, 1,600 Class B shares, and warrants to purchase 1,479 Class B shares.
• · Weighted average Class B shares outstanding surged from 27,625 in H1 2025 to 486,497 in H1 2026, reflecting significant equity issuance.

13-08-2026

King Resources, Inc. reported a net loss of $962,587 for the quarter ended June 30, 2026, a significant increase from a net loss of $307,611 in the same quarter last year. Revenue dropped to zero from $19,221 in the prior-year quarter, and operating expenses more than tripled to $973,650, driven by a surge in sales and marketing expenses. The company's cash position improved to $22,969 from $8,789 at the end of March 2026, but total liabilities exceeded total assets, resulting in a stockholders' deficit of $1,292,906.

• · Sales and marketing expenses increased to $868,296 from $251,074 YoY.
• · General and administrative expenses increased to $105,354 from $64,225 YoY.
• · Stock-based compensation expense of $854,700 was recognized in Q1 FY2027.
• · The company recorded a gain of $45,385 from forgiveness of related party debts and a loss of $34,322 on closure of a subsidiary.
• · Total current liabilities increased to $1,542,588 from $1,465,519 at March 31, 2026.
• · Accumulated deficit widened to $10,590,144 from $9,627,557.
• · Net cash used in operating activities was $43,562, slightly higher than $42,933 in the prior year.
• · Cash provided by financing activities was $57,445 from advances from related parties.
• · The company has significant risks related to its Hong Kong operations and PRC regulations.

13-08-2026

Nuveen Global Cities REIT, Inc. reported net income of $12.5M for Q2 2026, reversing a $2.1M net loss in Q2 2025, driven by strong realized and unrealized gains from real estate-related securities and improved rental revenue. However, the REIT struggled with rising interest expense ($9.9M vs $11.4M YoY for Q2), a growing accumulated deficit ($645.2M vs $597.8M at Dec 2025), and a net redemption of common stock totaling $155.7M in H1 2026 (vs $131.2M in H1 2025), indicating persistent investor outflows despite operational improvements.

• · Total assets increased 3.1% from $2.73B at Dec 31, 2025 to $2.81B at June 30, 2026.
• · Total liabilities increased 8.0% from $991.7M at Dec 31, 2025 to $1.07B at June 30, 2026.
• · Common stock repurchases exceeded issuances in H1 2026 ($143.4M repurchased vs $125.4M issued), net cash outflow ~$18.0M.
• · Contributions from non-controlling interests surged to $26.8M in H1 2026 from $0.6M in H1 2025, a 45x increase.
• · Interest expense declined 12.5% YoY for Q2, but borrowing under credit facility increased to $91.0M in H1 2026 from $40.0M in H1 2025.
• · Realized/unrealized gain from real estate-related securities was $11.4M in Q2 2026 vs a loss of $1.5M in Q2 2025.

13-08-2026

Global-Smart.Tech Inc. (GSMT) filed its 10-K annual report for the fiscal year ended May 31, 2026, reporting a net loss of $103,768, an improvement from the $124,374 net loss in the prior year. Revenue surged over 11x to $79,156 from $6,868, driven by a significant increase in share issuances for cash ($7,203 vs $26,841 in FY25). However, the company's cash position collapsed to just $81 from $12,943, and its accumulated deficit deepened to $374,373, while total operating expenses rose 39% to $182,924, outpacing revenue growth.

• · Revenue increased to $79,156 from $6,868, a 1,053% jump, but this was from a very low base.
• · Operating expenses rose 39.4% to $182,924, driven by a 137% increase in General and Administrative Expenses to $65,285.
• · The company's cash balance fell 99.4% to just $81, down from $12,943.
• · The company is dependent on related-party loans ($434,425) and equity issuances to fund operations; it has a working capital deficit of $450,794.
• · No revenue was generated from core operations; the company has no deferred tax assets due to a full valuation allowance.
• · Loss per share remained flat at ($0.02) despite a 22% increase in weighted average shares outstanding.

13-08-2026

Provectus Biopharmaceuticals reported a net loss of $988,716 for Q2 2026, a significant improvement from the $1,852,081 loss in Q2 2025, driven by a 49.5% reduction in operating expenses. However, the company recorded zero grant revenue in Q2 2026 versus $57,480 in the prior year, and its accumulated deficit deepened to $265,126,832. Cash increased sharply to $1,156,915 from $251,291 at year-end 2025, primarily due to $1,621,050 in financing proceeds, but the company remains in a stockholders' deficit of $6,287,564.

• · Convertible notes payable (including related parties) increased to $3,310,000 at June 30, 2026 from $2,610,000 at December 31, 2025.
• · Total liabilities rose to $7,761,065 at June 30, 2026 from $7,000,220 at December 31, 2025.
• · Net cash used in operating activities improved to $715,814 in H1 2026 from $1,616,571 in H1 2025.
• · The company had no restricted cash at June 30, 2026, compared to $30,542 at June 30, 2025.
• · Non-cash conversion of 2025 Notes and related accrued interest to Series D-1 Preferred Stock totaled $1,074,935 in H1 2026.
• · Conversion of accrued directors' fees to Series D-1 Preferred Stock amounted to $542,501 in H1 2026.

13-08-2026

Adia Nutrition, Inc. reported a significant improvement in revenue for the three and six months ended June 30, 2026, driven by strong growth in medical procedures and biologics sales. Total revenue for the six-month period surged to $661,660 from $189,910 in the prior year, a 248% increase. However, the company remains unprofitable, with a net loss of $122,107 for the six months (improved from a $240,216 loss in 2025), and its total liabilities of $1,123,835 far exceed total assets of $744,054, resulting in a stockholders' deficit of $379,781.

• · Sales of supplements revenue was $0 for both the three and six months ended June 30, 2026, compared to $1,091 and $2,155 in the prior year periods.
• · Services revenue was $0 for both the three and six months ended June 30, 2026, compared to $2,267 in the prior year periods.
• · Research and development expenses were $0 for both the three and six months ended June 30, 2026, compared to $24,616 in the prior year periods.
• · Salaries and wages expenses were $55,129 and $87,731 for the three and six months ended June 30, 2026, compared to $0 in the prior year periods.
• · Clinical trial fees were $7,175 and $12,025 for the three and six months ended June 30, 2026, compared to $0 in the prior year periods.
• · Corporate filing fees were $7,723 and $11,728 for the three and six months ended June 30, 2026, compared to $0 in the prior year periods.
• · Public relations expenses were $2,480 and $4,920 for the three and six months ended June 30, 2026, compared to $0 in the prior year periods.
• · Repairs and maintenance expenses were $1,152 and $2,162 for the three and six months ended June 30, 2026, compared to $0 in the prior year periods.
• · Utilities expenses were $1,672 and $2,538 for the three and six months ended June 30, 2026, compared to $0 in the prior year periods.
• · Net cash used for operating activities was $164,078 for the six months ended June 30, 2026, compared to $167,541 in the prior year.
• · Net cash provided by financing activities was $223,596 for the six months ended June 30, 2026, compared to $293,120 in the prior year.
• · Proceeds from sale of common stock were $0 for the six months ended June 30, 2026, compared to $70,000 in the prior year.
• · Inventory increased by $115,475 during the six months ended June 30, 2026, compared to a decrease of $40,116 in the prior year.
• · Deferred revenue increased by $50,000 during the six months ended June 30, 2026, compared to $0 in the prior year.
• · Accrued interest – related party increased to $60,681 as of June 30, 2026 from $37,915 as of December 31, 2025.
• · The company had a stockholders' deficit of $379,781 as of June 30, 2026, worsening from a deficit of $257,674 as of December 31, 2025.
• · Weighted average shares outstanding (basic) were 94,404,696 for the six months ended June 30, 2026, compared to 92,770,810 in the prior year.

13-08-2026

Pismo Coast Village, Inc. reported net income of $585,000 for Q3 FY2026 (up 0.5% YoY from $582,000) and $696,000 for the nine months ended June 30, 2026 (up 64.9% from $422,000 in the prior year period). Revenue grew 6.1% YoY in Q3 to $3.09M and 10.0% YoY for the nine months to $7.63M, driven primarily by strong RV camping site rentals (+10.0% YoY for nine months). However, operating income for Q3 declined 8.4% YoY to $742,000, and retail sales and property lease income both decreased, reflecting mixed performance across segments.

• · Total assets increased 5.0% to $32.06M as of June 30, 2026 from $30.53M as of September 30, 2025.
• · Stockholders' equity rose to $26.69M from $25.99M, a 2.7% increase.
• · Cash reserved for capital improvements and deferred maintenance increased to $13.45M from $11.94M.
• · Customer deposits grew 39.1% to $3.61M from $2.60M.
• · Total liabilities increased 18.4% to $5.37M from $4.53M.
• · Nine-month net cash provided by operating activities was essentially flat at $1.88M (up from $1.89M in prior period).
• · Nine-month capital expenditures rose 53.6% to $278,000 from $181,000.
• · Property, plant and equipment (net) was nearly unchanged at $16.58M.
• · Income tax provision for Q3 decreased 22.4% YoY to $257,000 from $331,000.

13-08-2026

MultiSensor AI Holdings, Inc. (MSAIW) filed its 10-Q for the quarter ended June 30, 2026, reporting net revenue of $1,695K for Q2 2026, up 19.4% from $1,419K in Q2 2025, driven by strong software revenue growth of 84.8% to $739K. However, services revenue declined 82.1% to $26K, and the company continued to post a net loss of $2,460K, though this was an improvement from a $3,322K loss in the prior-year quarter. Cash and cash equivalents decreased to $21,005K from $24,365K at year-end 2025.

• · Contract liabilities (current) increased to $2,950K from $1,255K at year-end 2025, a 135% increase.
• · Trade accounts receivable, net, increased to $3,624K from $1,670K at year-end 2025, a 117% increase.
• · Inventories (current) decreased to $3,332K from $4,020K at year-end 2025.
• · Accumulated deficit grew to $(71,270K) from $(66,339K) at year-end 2025.
• · Net cash used in operating activities for H1 2026 was $4,080K, slightly worse than $3,980K in H1 2025.
• · Capital expenditures decreased to $372K in H1 2026 from $929K in H1 2025.
• · Proceeds from stock issuances were $1,046K in H1 2026, down from $4,739K in H1 2025.
• · Weighted-average basic shares outstanding increased to 2,069,434 in Q2 2026 from 838,785 in Q2 2025.
• · Internal-use software, net, increased to $7,169K from $6,800K at year-end 2025.

13-08-2026

Silo Pharma reported a net loss of $832,829 for Q2 2026 (improved from a $1,204,293 loss in Q2 2025) and a net loss of $2,479,946 for H1 2026 (wider than the $2,235,730 loss in H1 2025). Revenue fell to zero in Q2 2026 from $18,025 in Q2 2025, and gross profit turned negative for H1 2026 at ($2,662) versus $33,132 in H1 2025. Cash and cash equivalents declined to $3,277,095 from $4,748,700 at year-end 2025, while total assets fell to $5,952,023 from $7,605,100.

• · The company recorded a $714,000 non-cash expense for common stock issued for acquired technology in H1 2026.
• · A contingently returnable sublicense fee of $703,552 was recognized as a current liability as of June 30, 2026, with a corresponding reclassification from deferred revenue.
• · Crypto assets at fair value decreased to $205,414 from $221,817 at year-end 2025, with an unrealized loss of $89,143 recognized in H1 2026.
• · Research and development expenses remained nearly flat at $1,311,683 in H1 2026 versus $1,311,209 in H1 2025.
• · The company executed a 1-for-15 reverse stock split during Q2 2026, resulting in 44,169 rounding shares issued.
• · Net cash used in operating activities improved to $1,604,484 in H1 2026 from $2,925,568 in H1 2025, a 45.2% reduction.
• · Short-term investments at fair value were $1,950,147 as of June 30, 2026, compared to $2,110,065 at December 31, 2025.

13-08-2026

Elmet Group Co. reported a net loss of $4.488M for Q2 FY26 and $4.826M for H1 FY26, compared to net income of $1.240M and $2.437M in the prior-year periods, respectively. Revenue grew 35.1% YoY in Q2 to $66.401M and 28.2% YoY in H1 to $122.408M, driven by strong top-line expansion. However, operating expenses surged, particularly general and administrative costs which rose 342.7% in Q2, leading to an operating loss of $7.628M versus a $3.246M operating income a year ago. The company completed an IPO during the quarter, raising $125.363M in net proceeds, which significantly strengthened its cash position to $66.122M from $1.759M at year-end 2025.

• · The company completed an initial public offering (IPO) during Q2 FY26, issuing 9,857,142 shares of Common Stock and raising $125.363M in net proceeds.
• · All Class A Common Stock (20,122,721 shares) and Class B Common Stock (466 shares) were converted to Common Stock in connection with the IPO.
• · General and administrative expenses surged to $17.780M in Q2 FY26 from $4.016M in Q2 FY25, a 342.7% increase, largely due to stock-based compensation of $10.090M in the quarter.
• · Research and development expenses increased 328.2% YoY to $4.321M in Q2 FY26.
• · Inventories grew 47.0% to $102.401M from $69.697M at year-end 2025, driven by a 160.8% increase in raw materials to $28.257M.
• · The company reported a net loss per share (basic and diluted) of ($0.16) for Q2 FY26 versus earnings per share of $0.06 in Q2 FY25.
• · Cash used in operating activities from continuing operations was $7.572M in H1 FY26, compared to cash provided of $9.024M in H1 FY25.
• · The company had no discontinued operations in FY26, compared to a loss from discontinued operations of $1.546M in H1 FY25.
• · Total liabilities decreased to $96.685M from $115.189M at year-end 2025, primarily due to repayment of long-term debt and related party debt.
• · The company's effective tax rate was negative in Q2 FY26 due to a $3.750M income tax benefit, compared to $0 provision in Q2 FY25.

13-08-2026

Energous Corp reported a net loss of $2.9M for Q2 2026, slightly wider than the $2.8M loss in Q2 2025, while revenue surged 217% YoY to $3.1M. However, gross profit margin collapsed from 34.7% to just 3.0% as cost of revenue grew much faster than sales, and operating expenses rose 5.4% YoY. The company strengthened its balance sheet by raising $31.9M net from an ATM offering, boosting cash to $31.2M, but its accumulated deficit deepened to $414.6M.

• · Gross profit margin fell from 34.7% in Q2 2025 to 3.0% in Q2 2026, as cost of revenue ($3.0M) nearly equaled revenue ($3.1M).
• · Operating expenses for Q2 2026 increased 5.4% YoY to $3.3M, driven by higher G&A ($1.5M vs $1.3M) and R&D ($1.1M vs $1.1M).
• · Cash used in operating activities worsened to $10.9M in H1 2026 from $7.5M in H1 2025.
• · Prepaid expenses and other current assets surged from $422K at Dec 2025 to $6.9M at Jun 2026, primarily due to a $6.3M deposit with contract manufacturers.
• · The company issued 3.3M shares via ATM in H1 2026, raising $31.9M net, compared to 850K shares for $15.8M net in H1 2025.
• · Weighted average shares outstanding increased from 1.2M in Q2 2025 to 5.5M in Q2 2026, diluting EPS from ($2.35) to ($0.53).

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

13-08-2026

YETI Holdings reported strong Q2 FY26 results with net sales of $483.9M, up 8.5% YoY from $445.9M, and net income of $71.3M, a 39.4% increase from $51.2M. However, cash decreased sharply by $128.5M to $59.8M, driven by $131.0M in stock repurchases and heavy investment in working capital, while total stockholders' equity fell 6.3% to $609.5M from $650.3M at year-start.

• · Cash from operations was $29.8M in H1 FY26 vs. -$19.1M in H1 FY25, a significant improvement.
• · Inventory increased 23.6% to $359.1M from $290.6M at year-start, indicating potential buildup.
• · Accounts receivable rose 23.6% to $174.8M from $141.4M.
• · Total debt (current + long-term) increased to $100.8M from $73.5M at year-start, driven by $30M net borrowings under revolving credit facility.
• · SG&A expenses grew 17.1% YoY in Q2 to $229.0M, outpacing sales growth.
• · Product recalls and impairment of long-lived assets totaled $4.2M in H1 FY26 (none in prior period).
• · Weighted-average basic shares outstanding declined 9.7% YoY to 74.7M in Q2, reflecting buyback impact.

13-08-2026

X-Energy, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, reporting a significant increase in total revenues and grant income to $98.0M for the six months ended June 30, 2026, up from $42.3M in the prior-year period, driven by a 165% increase in services revenue. However, operating expenses more than doubled to $274.2M, leading to a net loss of $271.6M compared to $99.1M in the prior period. The company completed its initial public offering (IPO) during the quarter, raising $1.1B in net proceeds and converting all mezzanine equity into common stock, resulting in a substantial improvement in its balance sheet with total stockholders' equity of $2.1B as of June 30, 2026, compared to a deficit of $1.2B at year-end 2025.

• · The company completed its IPO during the quarter, issuing 50,892,857 shares of Class A common stock and raising $1.1B in net proceeds.
• · All mezzanine equity (Class A and B common units and preferred units) was converted to common stock as part of the Reorganization Transactions, eliminating $2.1B in mezzanine equity.
• · Warrant liabilities were reduced to $0 from $274.2M at year-end 2025, with a mark-to-market loss of $114.5M recognized in the six-month period.
• · Accounts receivable from the DOE increased to $40.3M from $23.6M at year-end 2025.
• · Unbilled receivables and contract assets from the DOE increased to $70.0M from $39.6M at year-end 2025.
• · Research and development expenses decreased to $299K for the six months ended June 30, 2026, from $1.2M in the prior-year period.
• · Net loss per share (Class A common stock, basic and diluted) was $(0.21) for both the three and six months ended June 30, 2026.
• · Non-controlling interests totaled $280.9M as of June 30, 2026, reflecting the portion of losses and equity attributable to other equity holders.

13-08-2026

Gyrodyne, LLC filed its 10-Q for the period ended June 30, 2026, reporting net assets in liquidation of $27.06 million, up from $25.86 million at December 31, 2025. Cash and cash equivalents decreased to $3.77 million from $4.53 million, while total assets fell to $57.92 million from $58.69 million. The company continues to hold $53.99 million in real estate held for sale and expects gross real estate proceeds of $53.99 million, though incremental value from a pending sewer treatment plant amenity is not included as it is not estimable.

• · All 91,628 Stock Plan shares were issued effective November 14, 2023; no remaining shares issuable.
• · The B2K agreement (dated July 30, 2025, amended January 6, 2026) provides a closing credit of $4.02M for infrastructure costs.
• · Incremental value from the pending STP amenity is not included in gross real estate proceeds as it is not estimable.
• · Estimated final liquidation and dissolution costs are $1.48M.
• · Interest income is expected to be offset by interest expense and working capital settlement, resulting in a net balance of ($5.85M).

13-08-2026

Jones Soda Co. reported Q2 2026 revenue of $10.2M, more than doubling from $4.9M in Q2 2025, driven by strong growth in its hemp-derived HD9 products. However, the company posted a net loss of $650K for the quarter, compared to net income of $2.6M in the prior-year period which included a $3.7M gain on disposition of subsidiaries. Operating loss narrowed to $525K from $760K, but cash used in operations increased to $2.9M in H1 2026 from $2.6M in H1 2025, and total assets declined to $13.7M from $15.2M at year-end 2025.

• · Gross profit improved to $2.8M in Q2 2026 from $1.6M in Q2 2025, and to $6.7M in H1 2026 from $3.0M in H1 2025.
• · Selling and marketing expenses rose to $1.9M in Q2 2026 from $1.1M in Q2 2025, and to $3.9M in H1 2026 from $2.2M in H1 2025.
• · General and administrative expenses increased slightly to $1.4M in Q2 2026 from $1.3M in Q2 2025, and to $2.9M in H1 2026 from $2.5M in H1 2025.
• · Inventories increased to $4.7M as of June 30, 2026 from $2.7M at December 31, 2025.
• · Accounts receivable decreased to $3.3M from $3.6M, while accounts payable decreased to $5.3M from $6.4M.
• · Revolving credit facility and loans increased to $3.7M from $3.0M.
• · Net cash used in continuing operations was $2.9M in H1 2026 vs $2.6M in H1 2025.
• · The company sold a note receivable for $1.4M in H1 2026, providing investing cash inflow.
• · Weighted average diluted shares outstanding increased to 118.8M in Q2 2026 from 116.2M in Q2 2025.
• · The company faces risks related to potential federal legislation banning unregulated sale of intoxicating hemp-derived products, which could impact HD9 revenue.

13-08-2026

Quality Industrial Corp. reported a net loss attributable to stockholders of $23,474 for the six months ended June 30, 2026, a significant improvement from a loss of $1,602,091 in the prior year period. Revenue declined 5.7% to $7,199,666, but operating income turned positive at $307,950 versus a loss of $506,663. Cash and cash equivalents decreased sharply from $426,585 to $150,012, and the company continues to have a working capital deficit.

• · Total current liabilities exceed total current assets by $10,759,635 as of June 30, 2026, indicating a working capital deficit.
• · Operating income for the three months ended June 30, 2026 was $132,130, down from $440,459 in the same period last year.
• · Net cash used in operating activities for the six months ended June 30, 2026 was $341,094, compared to $514,600 used in the prior year period.
• · The company issued 5,655,811 shares from conversion of convertible notes during the six months ended June 30, 2026.
• · All 8,500 Series B preferred shares were converted to common stock during the six months ended June 30, 2026.
• · Weighted average basic shares outstanding increased from 144,560,007 to 190,418,220 for the six months ended June 30, 2025 and 2026, respectively.

13-08-2026

Alexander Tech Corp filed its 10-K annual report for the fiscal year ended April 30, 2026, reporting no revenue and a net loss of $50,700, a slight improvement from a net loss of $51,261 in the prior year. The company's cash position declined 35% to $7,046 from $10,856, while total liabilities increased to $414,610 from $367,491, driven by higher due to related party and accounts payable. The company continues to operate with a significant accumulated deficit of $861,551 and a stockholders' deficit of $407,335, reflecting ongoing financial challenges.

• · The company has no revenue and relies on related-party loans to fund operations.
• · Accounts payable and accrued liabilities surged from $615 to $24,235, a 3,841% increase.
• · Due to related party increased 7.2% to $348,374, representing 84% of total liabilities.
• · Net cash used in operating activities improved 45.4% to $27,309 from $50,013, primarily due to a $23,620 increase in accounts payable.
• · The company's business strategy is to acquire undervalued or sub-optimally managed businesses, but no acquisitions have been completed to date.
• · Weighted average shares outstanding remained constant at 268,725 for both periods.